The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Research Grant, 2013Is ATP13A2 a Lysosomal Lipid Flippase that Affects Alpha-synuclein Membrane Interactions?
Promising Outcomes of Original Grant:
One of the objectives of the original study was the development of biochemical and cell-based assays for measuring ATP13A2 protein activity. We largely achieved... -
Synuclein Therapeutic Acceleration Program, 2013Immunotherapy with Alpha-synuclein Specific Antibody
Objective/Rationale:
The protein alpha-synuclein is believed to play a major role in the development of Parkinson’s disease (PD). Toxic forms of alpha-synuclein can cause neuronal... -
Research Grant, 2013A New Pharmaceutical Target for Mono and Add-on Therapy in Parkinson’s Disease
Objective/Rationale:
We are targeting a molecule, for the first time in Parkinson’s research, that is only present in the human brain’s motor circuitry and that we believe will respond to... -
LRRK2 Challenge, 2013Direct Activity Sensor for Interrogating LRRK2 in Complex Biological Samples
Objective/Rationale:
Mutations in Leucine-Rich Repeat Kinase 2 (LRRK2) that increase the kinase’s activity – transferring groups of chemicals called phosphates – have been associated with... -
Research Grant, 2013LRRK2 Phosphatases Confirmation
Promising Outcomes of Original Grant:
The molecular events that precipitate the onset of Parkinson’s disease (PD) have yet to be precisely defined; however current research indicates that the Leucine... -
Dyskinesia Challenge, 2013Deciphering the Role of Histone Deacetylase in Levodopa-Induced Dyskinesia
Objective/Rationale:
It is well known that repeated administration of levodopa causes gradual changes in striatal gene expression that eventually result in the development of levodopa-induced...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.